Sales & Marketing

With biopharma sales and marketing changing faster than ever, it’s become crucial for brands to stay relevant with each new product launch. Christopher Price shares his point of view through the lens of 20 years of experience in the space.

Building on Morgan Health’s accountable care strategy, Dr. Pegus will help inform the team’s renewed focus on population-based health initiatives, including investing in and scaling promising new care delivery models designed to improve health outcomes, particularly among diverse populations.

80% of Rx Patients Currently See Providers with Access to POC Media.

In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.

Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST

Healthcare marketing leader Lasso powers a unique endemic HCP campaign, reaching 70% more providers than the benchmark and fueling 30% lift in new prescription activity.

The partnership enables clinical trial sponsors to pressure test protocol designs with Savvy Cooperative patients through ProofPilot's digital protocol interface.

The move reflects Fingerpaint Group's commitment to innovate its capabilities as clients' needs evolve.

The scale up of omnichannel operations intends to create a more personalized experience across the globe.

Ten-year partnership will help Merck reduce operational costs, deliver value to patients, and optimize the healthcare professional and patient experience.

The honor recognizes agencies that have achieved significant growth over the past three years.

Schappell and Warker join social health company Health Union to accelerate innovation and position the company for exponential growth.

Industry veteran Helen Kim has joined long-standing out of home specialist agency EMC Outdoor as senior vice president of client services.

On the occasion of the German Pain Congress 2022 (Deutscher Schmerzkongress 2022) the CNS-specialist announces Change for Health campaign.

The acquisition by ILSL Inc., a subsidiary of Indegene Private Limited, augments Indegene’s commercialization portfolio spanning drug discovery and development to marketing and sales, adding brand strategy, market development capabilities, and patient engagement platforms.

Two additional leadership moves also strengthen management team.

Pharmaceutical Executive presents the 2022 APEX Awards, which is presented by a jury of HCPs for breakthroughs in pharmaceutical and healthcare marketing and communications.

Elevalt’s 4Ps proprietary algorithms are the culmination of 6 years of refining omnichannel execution and are the foundation of the company’s data-driven approach to commercialization.

Follows recent launch of DeepIntent's innovative "Patient Planner" to simplify audience creation and campaign activation.

There has been a push to implement NFTs, or non-fungible tokens, across many verticals, but there is still much to learn about their potential uses in healthcare and its brands.

New managing director Trevor Pill has been passed the company's helm from founder Karen Winterhalter.

The highly-regulated pharmaceutical industry poses serious challenges that can derail digital health programs. But, there are solutions.

Leo Tarkovsky brings more than 25 years of proven experience scaling companies in the healthcare space.

Under its Commercial License Agreement with OBT, Genmab will obtain the exclusive right to develop and commercialize novel antibody therapeutics utilizing OBT's novel, first-in-class IO antibody.

Fast-growing specialty pharma selects Veeva CRM and Veeva Vault PromoMats to build a unified foundation for commercial excellence.